[{"id":"cb86389f-61b0-4727-9f4f-d7c9289d9301","acronym":"","url":"https://clinicaltrials.gov/study/NCT05747157","created_at":"2023-02-28T13:01:20.134Z","updated_at":"2024-07-02T16:35:28.514Z","phase":"Phase 1","brief_title":"Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research","source_id_and_acronym":"NCT05747157","lead_sponsor":"Anhui Provincial Hospital","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • Meta10-19"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 02/15/2023","start_date":" 02/15/2023","primary_txt":" Primary completion: 02/01/2025","primary_completion_date":" 02/01/2025","study_txt":" Completion: 05/15/2025","study_completion_date":" 05/15/2025","last_update_posted":"2023-11-21"},{"id":"1e9a0fed-aa81-40d5-835d-c166a3f33f32","acronym":"","url":"https://clinicaltrials.gov/study/NCT06120166","created_at":"2023-11-07T16:14:25.295Z","updated_at":"2024-07-02T16:35:30.192Z","phase":"Phase 1","brief_title":"Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research","source_id_and_acronym":"NCT06120166","lead_sponsor":"He Huang","biomarkers":" MYC • BCL2 • CD19 • BCL6 • IL6","pipe":" | ","alterations":" CD19 expression • BCL2 translocation","tags":["MYC • BCL2 • CD19 • BCL6 • IL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression • BCL2 translocation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • Meta10-19"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 11/20/2023","start_date":" 11/20/2023","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 04/05/2026","study_completion_date":" 04/05/2026","last_update_posted":"2023-11-07"},{"id":"63726d75-4948-4ffb-bda7-e67f19bf129f","acronym":"","url":"https://clinicaltrials.gov/study/NCT05715606","created_at":"2023-02-08T18:00:09.810Z","updated_at":"2024-07-02T16:35:44.038Z","phase":"Phase 1","brief_title":"Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research","source_id_and_acronym":"NCT05715606","lead_sponsor":"Anhui Provincial Hospital","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • Meta10-19"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 02/10/2023","start_date":" 02/10/2023","primary_txt":" Primary completion: 02/01/2025","primary_completion_date":" 02/01/2025","study_txt":" Completion: 05/15/2025","study_completion_date":" 05/15/2025","last_update_posted":"2023-07-04"}]